Data de publicação: 24/09/2020 - 12:47
An international project, of which Fiocruz Pernambuco is part, is evaluating public health response to Covid-19 in Brazil, Canada, China, France, and Mali. Researchers will compare data obtained in the five countries, to identify the strong and weak points of the measures adopted, including the challenges faced by health professionals and health systems. The goal is to gather the lessons learned, based on strict interdisciplinary researches...
Notícias
Data de publicação: 24/09/2020 - 12:17
In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The trial, which was initially expected to be carried out only in the state of Mato Grosso do Sul, will be expanded to the state of Rio de Janeiro.
Coordinated in Brazil by Fiocruz...
Notícias
Data de publicação: 11/09/2020 - 12:22
Researchers of Fiocruz and Visuri, reference institutions in research and development of technology for health, have developed a portable device, the OmniLAMP, for the molecular diagnosis of COVID-19 through the detection of SARS-CoV-2 genetic material. Using the RT-LAMP technique, which transforms RNA into DNA and amplifies it isothermically, the equipment makes it possible to run tests with safety levels similar to those of the PCR (polymerase...
Notícias
Data de publicação: 25/08/2020 - 15:19
The Oswaldo Cruz Foundation (Fiocruz), in a partnership with the Community Council of Manguinhos, Redes da Maré, Dados do Bem, SAS Brasil and União Rio, is launching an innovative project that makes possible full healthcare in the favelas, and will contribute to face the Covid-19 pandemic in the communities of Maré and Manguinhos, in Rio de Janeiro. Conexão Saúde: de olho na Covid (Health Connection: keeping an...
Notícias
Data de publicação: 25/08/2020 - 13:53
The new coronavirus pandemic has been posing unheard-of challenges to health information systems. Covid-19 data in Brazil, both at a state and municipal level, are crucial for the decision making on public policies and emergency measures to contain the pandemic. These data, however, depend on systems and panels whose coverage and quality vary wildly all over the country. This is the conclusion of a Fiocruz paper, which states that the release of...
Notícias
Data de publicação: 25/08/2020 - 11:00
Brazilian researchers have taken the first step in the development of a simple and cheap method to disinfect surfaces and hands. Laboratory tests have shown that a film of detergent can turn inactive the aviary coronavirus (a virus that causes flu in birds and that belongs to the same family of the SARS-CoV-2, the agent of Covid-19). Based on these good results, scientists will now evaluate the action of the formula against SARS-CoV-2 in the...
Notícias
Data de publicação: 19/08/2020 - 17:05
Fiocruz President, Nísia Trindade Lima, is the co-chair of the Group on Economic Response and Recovery of the initiative created by research funding agencies to develop a United Nations Research Roadmap for the Recovery of Covid-19. The work was commissioned by the United Nations Deputy Secretary-General, Amina Mohammed, and will be a complementary document to the UN Framework for the immediate socio-economic response to COVID-19.
The...
Notícias
Data de publicação: 17/08/2020 - 12:13
Since the confirmation of the first cases of Covid-19, Fiocruz, an institution linked to the Ministry of Health, has been working to provide responses in different areas. After developing molecular tests to detect the disease and progressively increasing their production scale, the Foundation now begins the operation of one more Support Unit to the Diagnostic of Covid-19 (click here for a virtual tour of the Unit). The initiative is...
Notícias
Data de publicação: 06/08/2020 - 17:07
The Fiocruz Global Health Center (Cris/Fiocruz), the National School of Public Health (Ensp/Fiocruz), the Network of Public Health Schools in Latin America (Resp-AL), the Latin American Alliance for Global Health (Alasag), the Argentine Network of Public Health Schools and the International Network of Health Technicians (Rets), which usually act in partnership, promoted the international seminar Vaccines and medicines for Covid-19 as global...
Notícias
Data de publicação: 06/08/2020 - 12:28
Covid-19 has shown Brazil’s fragility in promoting an industrial policy in the health area: facing the pandemic involves prevention, services preparation, drugs, equipment, diagnostic tests, and the future vaccine. When one of these parts fails the entire strategy to contain the disease’s expansion will be jeopardized. This is Carlos Gadelha’s evaluation, a researcher and coordinator of Prospection Actions at Fiocruz. “...
Notícias
Data de publicação: 04/08/2020 - 10:54
Many of us have greatly been affected by Covid-19 - from loss of jobs, closure of schools, travel bans, movement restriction and much more. However, some groups of people have been more affected other than others, and the more vulnerable in the community, societies and groups have borne the greatest brunt. The disease has affected men, women and people of other genders differently.
Various questions and concerns were raised during a...
Notícias
Data de publicação: 03/08/2020 - 13:49
Researchers from the Oswaldo Cruz Foundation develop a plan to support the fight against Covid-19 among indigenous peoples. One of the goals is to intensify surveillance and improve information about the impacts of the pandemic on these populations, through six lines of action. The initiative mobilized different units and vice-presidencies and was highlighted by the president of Fiocruz, Nísia Trindade Lima. “This is a joint action...
Notícias
Data de publicação: 27/07/2020 - 17:33
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) and by the Federal University of Juiz de Fora (UFJF), in collaboration with hospitals and research centers in Rio de Janeiro, provides new information that helps understand one of the most severe and frequent complications observed in Covid-19 patients hospitalized in intensive care units (ICUs). Published in “Blood”, the main international scientific journal in the area of...
Notícias
Data de publicação: 15/07/2020 - 11:30
Originally published at Reports in Public Health
In 2020, the COVID-19 pandemic has plunged nearly the entire planet into a health and humanitarian crisis, testing the human species in various dimensions. So many doubts raise the following question: is COVID-19 an inevitable phenomenon, given the relationship humans have with the various ecosystems and the other animal and plant species? Or in a simplified approach, is COVID-19 the episodic (...
Notícias
Data de publicação: 14/07/2020 - 12:13
Fiocruz president, Nísia Trindade Lima, is one of the members of the Lancet Covid-19 Commission. Led by American economist Jeffrey Sachs, the commission is an interdisciplinary initiative that includes leaders in health sciences, business, finances, and public policies, to formulate recommendations to overcome the challenges brought by the pandemic.
“The Commission was created to help speed up global, equitable, and long...
Notícias
Data de publicação: 14/07/2020 - 11:56
With the goal of better understanding the beginning of the novel coronavirus pandemic in Brazil, researchers of the Oswaldo Cruz Foundation (Fiocruz) have carried out a wide genetic study involving almost a hundred samples from patients from all Brazilian regions, infected by the SARS-CoV-2 virus in the early moments of the pandemic in national territory.
The study was led by specialists of the Respiratory Viruses and Measles Laboratory,...
Notícias
Data de publicação: 13/07/2020 - 17:18
Deaths in the city of Rio de Janeiro have increased by 64% in ths months of April and May 2020, when compared to the average in this same period in the last 3 years. In addition, a detailed analysis of the records shows a disturbing figure: deaths out of hospitals (both in health units, clinics, and other basic healthcare venues and at home) have practically doubled. This may be an indicator that, early in the epidemic, the city’s hospital...
Notícias
Data de publicação: 10/07/2020 - 15:19
Last week (July 1 and 2), the World Health Organization (WHO) hosted the second Global Research and Innovation Forum for Covid-19, with the participation of scientists of the Oswaldo Cruz Foundation (Fiocruz). The Forum, that took place online, had the goal of updating what is currently known about the disease and what are the gaps, where research must invest. The final goal is to speed up the development of knowledge on the subject.
The...
Notícias
Data de publicação: 10/07/2020 - 12:50
A study by researchers of the CoVida Network - Science, Information and Solildarity showed that the measures to contain Covid-19 in Brazil have already saved millions of lives, but they are not enough to slow down the spread of the pandemic in Brazil. According to mathematical analysis, even in the states that were stricter in terms of social distancing measures since the beginning of the transmission of the country, this set of actions is still...
Notícias
Data de publicação: 30/06/2020 - 17:59
The Oswaldo Cruz Foundation (Fiocruz) will sign an agreement with pharmaceutical company AstraZeneca for the acquisition of batches and transference of technology regarding the Covid-19 vaccine developed by the University of Oxford. The agreement will be the result of the cooperation between the Brazilian government and the pharmaceutic company, announced last Saturday, June 27, by the Ministry of Health.
This is a Advance Purchase Agreement...
Notícias
Data de publicação: 29/06/2020 - 15:14
Although respiratory symptoms are the best-known face of Covid-19, post-traumatic stress (PTSD), depression, and anxiety have also been described in patients with the disease. In an article published in Frontiers in Immunology, researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) and of Universidade Federal Fluminense (UFF), in the state of Rio de Janeiro, discuss how the new coronavirus can affect mental health, pointing to neural,...
Notícias
Data de publicação: 18/06/2020 - 15:52
Almost R$ 6 million (around US$1,2 million) in tests for Covid-19, personal protective equipment (PPE) and test devices will be donated to state of Amazonas to face the new coronavirus. The material will be transferred by the Oswaldo Cruz Foundation (Fiocruz) Program, United Against Covid-19.
The distribution of products will be monitored by Leônidas & Maria Deane Institute (ILMD / Fiocruz Amazônia), explains the researcher...
Notícias
Data de publicação: 12/06/2020 - 11:57
The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be assessed in animal models. The synthetic form of the vaccine was chosen for being quicker than traditional methodologies, for its lower production costs, the stability of the...
Notícias
Data de publicação: 09/06/2020 - 17:18
During the first weeks of social distancing due to the Covid-19 epidemic, a great part of the Brazilian population reported mood issues. Forty percent felt sad or depressed and 54% felt anxious or nervous frequently. The percentages were even higher among young adults (between 18 and 29 years old): 54 and 70%, respectively.
This is one of the many results identified in the first phase of ConVid - Behavior Research, which aimed to...
Notícias
Data de publicação: 01/06/2020 - 16:56
The Fiocruz against Covid-19 will benefit, all over the country, 145 projects that focus on vulnerable populations, such as quilombos (rural afro-brazilian settlements), indigenous peoples, riverside populations and favela dwellers. The initiative reaches more than 80 municipalities in all Brazilian states. The projects were selected through a Public Call for Support to Emergency Actions against Covid-19 in Vulnerable Populations...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
